The Current Ratio as of September 2024 (TTM) for Histogen Inc. (HSTO) is 4.05

According to Histogen Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.05. This represents a change of -48.46% compared to the average of 7.85 of the last 4 quarters.

Histogen Inc. (HSTO) Historical Current Ratio (quarterly & annually)

How has HSTO Current Ratio performed in the past?

The mean historical Current Ratio of Histogen Inc. over the last ten years is 7.13. The current 4.05 Current Ratio has changed 5.57% with respect to the historical average. Over the past ten years (40 quarters), HSTO's Current Ratio was at its highest in in the December 2013 quarter at 20.20. The Current Ratio was at its lowest in in the December 2019 quarter at 1.78.

Histogen Inc. (HSTO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Histogen Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Histogen Inc. (HSTO) Average Current Ratio

How has HSTO Current Ratio performed in the past?

The current Current Ratio of Histogen Inc. (HSTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Histogen Inc. (HSTO) Current Ratio vs. Peers

How is HSTO’s Current Ratio compared to its peers?

Histogen Inc.’s Current Ratio is less than Virax Biolabs Group Limited (25.94), greater than Baudax Bio, Inc. (0.07), greater than YS Biopharma Co., Ltd. (0.94), greater than NexImmune, Inc. (0.66), greater than Altamira Therapeutics Ltd. (1.38), less than Aileron Therapeutics, Inc. (4.69), less than Artelo Biosciences, Inc. (14.58), greater than Curis, Inc. (1.78), greater than Timber Pharmaceuticals, Inc. (0.50), less than SAB Biotherapeutics, Inc. (5.24), less than Senti Biosciences, Inc. (4.89), greater than Cingulate Inc. (1.20), greater than Bellicum Pharmaceuticals, Inc. (3.04), greater than Hillstream BioPharma, Inc. (2.25), greater than TRACON Pharmaceuticals, Inc. (0.66), less than Entera Bio Ltd. (7.41), greater than Tempest Therapeutics, Inc. (2.17), greater than Better Therapeutics, Inc. (0.57), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than Palisade Bio, Inc. (4.31), less than Bright Minds Biosciences Inc. (35.08), greater than Tonix Pharmaceuticals Holding Corp. (1.15),

Build a custom stock screener for Histogen Inc. (HSTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Histogen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Histogen Inc. (HSTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Histogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.